Klee Justin B. 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Klee Justin B.（CIK 1898314）在 1 家公司共报告 13 笔 SEC Form 4 内部人交易（最近一笔 2026-09-14）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-09-14 | Amylyx Pharmaceuticals, Inc. (AMLX) | Co-Chief Executive Officer | 卖出 | 29,025 | $932,553 |
| 2026-09-14 | Amylyx Pharmaceuticals, Inc. (AMLX) | Co-Chief Executive Officer | 卖出 | 1,439 | $47,710 |
| 2026-08-20 | Amylyx Pharmaceuticals, Inc. (AMLX) | Co-Chief Executive Officer | 买入 | 60,039 | $0 |
| 2026-03-09 | Amylyx Pharmaceuticals, Inc. (AMLX) | Co-Chief Executive Officer | 买入 | 248,865 | $0 |
| 2026-03-04 | Amylyx Pharmaceuticals, Inc. (AMLX) | Co-Chief Executive Officer | 卖出 | 29,282 | $423,711 |
| 2026-02-04 | Amylyx Pharmaceuticals, Inc. (AMLX) | Co-Chief Executive Officer | 卖出 | 15,500 | $227,695 |
| 2026-01-20 | Amylyx Pharmaceuticals, Inc. (AMLX) | Co-Chief Executive Officer | 买入 | 197,153 | $1.5M |
| 2026-01-20 | Amylyx Pharmaceuticals, Inc. (AMLX) | Co-Chief Executive Officer | 卖出 | 136,193 | $1.8M |
| 2026-01-20 | Amylyx Pharmaceuticals, Inc. (AMLX) | Co-Chief Executive Officer | 买入 | 2,847 | $21,552 |
| 2026-01-20 | Amylyx Pharmaceuticals, Inc. (AMLX) | Co-Chief Executive Officer | 卖出 | 1,995 | $27,711 |
| 2026-01-08 | Amylyx Pharmaceuticals, Inc. (AMLX) | Co-Chief Executive Officer | 卖出 | 7,715 | $85,559 |
| 2025-10-02 | Amylyx Pharmaceuticals, Inc. (AMLX) | Co-Chief Executive Officer | 卖出 | 29,775 | $427,867 |
| 2025-10-02 | Amylyx Pharmaceuticals, Inc. (AMLX) | Co-Chief Executive Officer | 卖出 | 200 | $3,002 |
来源：SEC Form 4 申报文件 · 截至 2026-09-14